AVITA Medical, Inc., a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, reported financial results for the first quarter March 31, 2023.
On July 23, 2018, Boston Scientific signed an agreement to purchase medical devices developerClaret Medicalfor an upfront cash payment of $220m. The terms of the agreement additionally include up to $50m as a potential reimbursement-based milestone payment. The Claret Medical portfolio includes the...
our ability to obtain coverage and reimbursement for procedures performed using our products; our ability to scale our organizational culture; the impact of the development, regulatory approval, efficacy and commercialization of competing products; the loss of key scientific or manageme...
About Premium Create free account Log inCreate a free Seeking Alpha account to access breaking news and valuable research tools »Create Free AccountSeeking Alpha - Power to Investors Power to Investors Follow us Download app Subscription Support: 1-347-509-6837 RSS Feed Sitemap Group Subscript...
In all versions of the protocol, after host depletion and DNA extraction, DNA was amplified using an optimised WGA protocol. Despite the potential ability of WGA to generate species-bias during amplification [52], this effect is less consequential when used on BSI samples as the majority of inf...
our ability to develop, manufacture, obtain and maintain regulatory approvals for, market and sell, our products; our expected future growth, including the size and growth potential of the markets for our products; our ability to obtain coverage and reimbursement for procedures p...
In recent years, the long-standing questions of why, how, and which farm families continue farming in the face of ongoing changes have increasingly been st
Because Romania has the highest mortality rate for cervical cancer in the EU, with about 11 deaths per 100,000 women annually, compared to the EU average of 3.4 [26] as of December 2023, Romania provides free HPV vaccines to boys and girls aged 11–18 and offers 50% reimbursement for wo...